Journal of Clinical Endocrinology & Metabolism, Vol 79, 1317-1321, Copyright © 1994 by Endocrine Society

ARTICLES

Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms

K Zeki, D Spambalg, N Sharifi, R Gonsky and JA Fagin
Division of Endocrinology, Cedars-Sinai Medical Center, University of California School of Medicine, Los Angeles 90048.

Several epidemiological studies have demonstrated an association between familial adenomatous polyposis coli (FAP) and thyroid neoplasms. Predisposition to FAP is conferred by mutations in the APC gene, located on chromosome 5q21. Somatic mutations of APC are also observed in about 60% of sporadic colorectal adenomas and carcinomas, suggesting that disruption of this putative tumor suppressor gene may play a role in both familial as well as acquired colorectal tumorigenesis. The APC gene is expressed in normal human thyroid, thyroid adenomas, and differentiated carcinoma tissues as well as in four clonal human thyroid carcinoma cell lines, as demonstrated by reverse transcriptase-polymerase chain reaction of a 388-base APC messenger ribonucleic acid fragment spanning exons 14 and 15, followed by hybridization to an exon 15-specific complementary DNA probe. Eighty human thyroid neoplasms were examined for loss of heterozygosity of the APC locus, using primers flanking a hypervariable dinucleotide (CA) repeat (CB26) immediately adjacent to the APC gene. Of 71% informative samples, 2 showed allelic loss: a follicular adenoma (FA) and a nodule from a multinodular goiter (MNG). The DNA of 83 benign and malignant thyroid neoplasms and 4 thyroid carcinoma cell lines was examined for mutations within a 1200-basepair stretch of exon 15 by single strand conformation polymorphism. Five sets of overlapping primers were used for PCR. The anaplastic thyroid carcinoma cell line (ARO) had 1 APC allele with an adenine insertion at codon 1556 (ACTA to AACTA), leading to a premature stop codon at 1558. An anaplastic carcinoma had a mutation of codon 1346 (TCA-CCA; Ser to Pro). In summary, the APC gene is expressed in normal and neoplastic human thyroid tissue and is a target for inactivating mutations in some thyroid tumors.

This article has been cited by other articles:

				K. D. McCall, N. Harii, C. J. Lewis, R. Malgor, W. Bae Kim, M. Saji, A. D. Kohn, R. T. Moon, and L. D. Kohn High Basal Levels of Functional Toll-Like Receptor 3 (TLR3) and Noncanonical Wnt5a Are Expressed in Papillary Thyroid Cancer and Are Coordinately Decreased by Phenylmethimazole Together with Cell Proliferation and Migration Endocrinology, September 1, 2007; 148(9): 4226 - 4237. [Abstract] [Full Text] [PDF]

				E. Puxeddu, S. Moretti, R. Elisei, C. Romei, R. Pascucci, M. Martinelli, C. Marino, N. Avenia, E. D. Rossi, G. Fadda, et al. BRAFV599E Mutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid Carcinomas J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2414 - 2420. [Abstract] [Full Text] [PDF]

				E. T. Kimura, M. N. Nikiforova, Z. Zhu, J. A. Knauf, Y. E. Nikiforov, and J. A. Fagin High Prevalence of BRAF Mutations in Thyroid Cancer: Genetic Evidence for Constitutive Activation of the RET/PTC-RAS-BRAF Signaling Pathway in Papillary Thyroid Carcinoma Cancer Res., April 1, 2003; 63(7): 1454 - 1457. [Abstract] [Full Text] [PDF]

				K. Ishigaki, H. Namba, M. Nakashima, T. Nakayama, N. Mitsutake, T. Hayashi, S. Maeda, M. Ichinose, T. Kanematsu, and S. Yamashita Aberrant Localization of {beta}-Catenin Correlates with Overexpression of Its Target Gene in Human Papillary Thyroid Cancer J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3433 - 3440. [Abstract] [Full Text] [PDF]

				K. Helmbrecht, A. Kispert, R. von Wasielewski, and G. Brabant Identification of a Wnt/{beta}-Catenin Signaling Pathway in Human Thyroid Cells Endocrinology, December 1, 2001; 142(12): 5261 - 5266. [Abstract] [Full Text] [PDF]

				F. Cetta, M. C. Curia, G. Montalto, M. Gori, A. Cama, P. Battista, and A. Barbarisi Thyroid Carcinoma Usually Occurs in Patients with Familial Adenomatous Polyposis in the Absence of Biallelic Inactivation of the Adenomatous Polyposis Coli Gene J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 427 - 432. [Abstract] [Full Text]

				F. Cetta, G. Montalto, M. Gori, M. C. Curia, A. Cama, and S. Olschwang Germline Mutations of the APC Gene in Patients with Familial Adenomatous Polyposis-Associated Thyroid Carcinoma: Results from a European Cooperative Study J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 286 - 292. [Abstract] [Full Text]

				J. A. Knauf, R. Elisei, D. Mochly-Rosen, T. Liron, X.-N. Chen, R. Gonsky, J. R. Korenberg, and J. A. Fagin Involvement of Protein Kinase Cepsilon (PKCepsilon ) in Thyroid Cell Death. A TRUNCATED CHIMERIC PKCepsilon CLONED FROM A THYROID CANCER CELL LINE PROTECTS THYROID CELLS FROM APOPTOSIS J. Biol. Chem., August 13, 1999; 274(33): 23414 - 23425. [Abstract] [Full Text] [PDF]

				F. Cetta Comment on Carney Complex and Related Syndromes and their Genetic Loci J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1491 - 1491. [Full Text]

				C. Soravia, S. L. Sugg, T. Berk, A. Mitri, H. Cheng, S. Gallinger, Z. Cohen, S. L. Asa, and B. V. Bapat Familial Adenomatous Polyposis-Associated Thyroid Cancer : A Clinical, Pathological, and Molecular Genetics Study Am. J. Pathol., January 1, 1999; 154(1): 127 - 135. [Abstract] [Full Text] [PDF]

				F. Cetta, G. Chiappetta, R. M. Melillo, M. Petracci, G. Montalto, M. Santoro, and A. Fusco The ret/ptc1 Oncogene Is Activated in Familial Adenomatous Polyposis-Associated Thyroid Papillary Carcinomas J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 1003 - 1006. [Abstract] [Full Text]

				J. A. Fagin Familial Nonmedullary Thyroid Carcinoma--The Case for Genetic Susceptibility J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 342 - 344. [Full Text] [PDF]